Oncologix Tech, Inc. is a diversified medical holding company with operating segments in medical device, healthcare services and medical products and technologies.
The company operates and manufactures Class II medical device products, delivers personal healthcare services nationally and provides home medical equipment (HME) and durabable medical equipment (DME) sales in licensed markets.
For its clients, the company provides the Food and Drug Administration (FDA) approved medical devices, Sta...
Oncologix Tech, Inc. is a diversified medical holding company with operating segments in medical device, healthcare services and medical products and technologies.
The company operates and manufactures Class II medical device products, delivers personal healthcare services nationally and provides home medical equipment (HME) and durabable medical equipment (DME) sales in licensed markets.
For its clients, the company provides the Food and Drug Administration (FDA) approved medical devices, State licensed healthcare services and medical product sales.
Segments
The company operates in three segments: Medical Device Manufacturing, Personal Care Services, and Medical Products Distribution and New Technologies.
Medical Device Manufacturing
Dotolo Research Corporation (DRC) designs, develops, manufactures and distributes the Toxygen hardware system with disposables speculums and tubing. The company has a valid registration from FDA as a Class II medical device, and is licensed by Health Canada, a CE mark for Europe.
The company’s products primary use is for colon and bowel preparation prior to medical procedures, such as a colonoscopy and OB/GYN medical procedures, and for individuals seeking health and wellness prevention and good colon health.
Trademarks, Licenses and Patents: Dotolo Research Corporation owns various patents, with it is primary patent on the Toxygen hardware, Patent # 5,788,650, ‘Colon Hydrotherapy Apparatus’- Ultra Violet Water Filtration System. This Patent is valid through 2018 and protects this product design both domestically and internationally.
Regulations: Advertising of the company’s products would be subject to both FDA and Federal Trade Commission regulations. These federal laws include the following: the anti-kickback statutes; the physician self-referral prohibition, commonly referred to as the Stark Law; the anti-inducement law; the Civil False Claims Act; and the Civil Monetary Penalties Law, which authorizes the U.S. Department of Health and Human Services (HHS) to impose civil penalties administratively for fraudulent or abusive acts.
Target Markets: The target markets and targeted customers for the company’s products include the following: health and wellness spas, endoscopy out-patient clinics, osteopathic physicians, hospital systems- veterans hospitals, skilled nursing homes, assisted living facilities, and individuals with disabilities, such as paraplegic, quadriplegic and obesity.
Strategy: As part of its growth strategy in the company’s health and wellness and medical device markets, the company would: re-strengthen and expand existing distribution channels s for medical device products within the United States; re-strengthen existing international distribution and re-seller agreements; release new product development on Version 2 of the Toxygen hardware system; and expand its factory operations to be able to accept large orders that would involve larger production runs.
Personal Care Services
Angels of Mercy, Inc. (AOM) provides non-medical, Personal Care Attendant (PCA) services, Supervised Independent Living (SIL), Long-Term Senior Care, and other approved programs performed by a trained caregiver that would meet the health service needs of beneficiaries whose disabilities preclude the performance of certain independent living skills related to the activities of daily living (ADL). PCA services that are reimbursed to AOM under the waiver include the following: assisting with personal hygiene, dressing, bathing, and grooming; performing or assisting in the performance of tasks related to maintaining a safe, healthy and stable living environment, such as light cleaning tasks in areas of the home used by the recipient, shopping for such items as health and hygiene products, clothing and groceries, performing activities of daily living inside and outside of the home which require attendant care, assisting with or performing beneficiary laundry care chores; assisting with bladder and/or bowel requirements, including bed pan routines; if indicated on the Plan of Care, assisting beneficiary to clinics, physician’s offices, and other appointments; assisting the beneficiary to receive any service specified in the written Plan of Care, including leisure skills development; and assisting in activities which would enhance the individual employability and improve and enhance the beneficiary’s quality of life.
Supervised Independent Living (SIL) is an alternative program for mentally challenged, developmentally disabled or physically disabled individuals. AOM provides the following personal health services: assistance with safety procedures and emergency contacts within the home environment; counseling during the transition period; assistance in meeting needs with medical management, employment, financial, budgeting, household management, personal care, recreation and transportation; accessibility to community resources; independence and personal growth; and freedom from abuse, neglect and exploitation.
Medical Products and Technologies
Esteemcare Inc.: Esteemcare, Inc. is a durable and home medical equipment and supply distributor for respiratory therapy and is accredited by the ‘Joint Commission on Healthcare Organizations’. Esteemcare, Inc. targets patients with sleep obstructive disorders or related chronic illnesses who are insured by Medicare, Medicaid, third-party insurers, or have the ability to pay for products from their own private resources. The company serves skilled nursing facilities; acute and critical care facilities; assisted living facilities; hospitals and medical institutions; federal agencies; home medical care industry; stroke centers; burn centers; and physical/occupational therapy centers.
Sales and Marketing: The company markets products directly to referral physicians, insurance payers, and consumers through direct push marketing activities.
History
Oncologix Tech, Inc. was founded in 1995. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in 2007.
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
